MGC Pharmaceuticals AU
Perth, AustraliaFounded 2014
About MGC Pharmaceuticals AU
MGC Pharmaceuticals is an ASX-listed bio-pharma company developing cannabinoid-based medicines. It operates production facilities in Europe with R&D based in Australia.
Key Facts
- 1Developing CannEpil for drug-resistant epilepsy through clinical trials
- 2EU-GMP production facility in Slovenia
Frequently Asked Questions
What is MGC Pharmaceuticals developing?
MGC is developing cannabinoid medicines including CannEpil for epilepsy and CogniCann for cognitive conditions.
Where does MGC manufacture?
MGC operates an EU-GMP certified facility in Slovenia for pharmaceutical cannabis production.
More Cannabis Companies in Perth
MXC Stock
View live price, chart & analysis
Products
- CannEpil epilepsy formulation
- CogniCann dementia trial product
- Pharmaceutical APIs
Specialties
Cannabinoid pharma R&DEuropean GMP productionClinical development
Company Details
- Type
- Medical & Pharma
- Location
- Perth, Australia
- Founded
- 2014
- Publicly Traded
- Yes
- Ticker
- ASX:MXC
Browse all Medical & Pharma
View more companies in this category
Related Companies
More in Australia
Althea Group
Melbourne \u2014 Medical & Pharma
ECS Botanics
Launceston \u2014 Producer & Grower
Cannatrek
Melbourne \u2014 Medical & Pharma
Levin Health
Melbourne \u2014 Medical & Pharma